FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/03/017895 [Registered on: 01/03/2019] Trial Registered Prospectively
Last Modified On: 28/02/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison between two doses of Dexmedetomidine through Epidural Infusion for Post-operative Pain Relief 
Scientific Title of Study   Comparison Between Two Different Doses of Dexmedetomidine through Continuous Epidural Infusion For Postoperative Analgesic Efficacy And Safety in Lower Limb Surgeries – Prospective Randomized Double-Blind Study  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sam Blessy Sheba 
Designation  PG Resident 
Affiliation  Sri Balaji Vidyapeeth 
Address  Department of Anaesthesiology Shri Sathya Sai Medical College and Research Institute Tiruporur-Guduvancherry Main Road, Chengalpet, Kancheepuram, Nellikuppam, Ammapettai

Kancheepuram
TAMIL NADU
603108
India 
Phone  8870065709  
Fax    
Email  bless_1203@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pranjali Kurherkar 
Designation  Professor 
Affiliation  Sri Balaji Vidyapeeth 
Address  Department of Anaesthesiology(2nd Floor) Shri Sathya Sai Medical College and Research Institute Tiruporur-Guduvancherry Main Road, Chengalpet, Kancheepuram, Nellikuppam, Ammapettai

Kancheepuram
TAMIL NADU
603108
India 
Phone  9486414942  
Fax    
Email  pranjalikurhekar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Sam Blessy Sheba 
Designation  PG Resident 
Affiliation  Sri Balaji Vidyapeeth 
Address  Department of Anaesthesiology(2nd Floor) Shri Sathya Sai Medical College and Research Institute Tiruporur-Guduvancherry Main Road, Chengalpet, Kancheepuram, Nellikuppam, Ammapettai

Kancheepuram
TAMIL NADU
603108
India 
Phone  8870065709  
Fax    
Email  bless_1203@hotmail.com  
 
Source of Monetary or Material Support  
Shri Sathya Sai Medical College and Research Institute  
 
Primary Sponsor  
Name  Sam Blessy Sheba 
Address  Department of Anaesthesiology Shri Sathya Sai Medical College and Research Institute Tiruporur-Guduvancherry Main Road, Chengalpet, Kancheepuram, Nellikuppam, Ammapettai, Tamil Nadu 603108 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Sam Blessy Sheba  Shri Sathya Sai Medical College and Research Institute  Department of Anaesthesiology 2nd Floor OT complex Tiruporur-Guduvancherry Main Road, Chengalpet, Kancheepuram, Nellikuppam, Ammapettai, Tamil Nadu 603108
Kancheepuram
TAMIL NADU 
08870065709

bless_1203@hotmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Human Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M96-M96||Intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Dexmedetomidine  Postoperative Continuous Epidural Infusion for analgesia Divided into two groups: •Group 1 will receive Epidural Infusion 0.1% Ropivacaine + 0.5µg/kg/24hours of Dexmedetomidine, total dose of 5ml/hr over period of 48 hours •Group 2 will receive Epidural Infusion 0.1% Ropivacaine + 1µg/kg/24hours of Dexmedetomidine, total dose of 5ml/hour over a period of 48 hours  
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients of both sex undergoing lower limb surgeries under Combined Spinal and Epidural Anaesthesia (CSEA) willing to be included in the study
 
 
ExclusionCriteria 
Details 
1.Patients with Cardiac pathology
2.Hypertension
3.BMI <18 or >30 kg/m2
4.Known allergy to local anaesthetic infiltration
5.Chronic use of any other analgesics
6.American Society of Anaesthesiologists (ASA) III and above
7.Pregnant patients
8.Refusal for consent


 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare analgesic efficacy in terms of Pain Scores in the first 24 hours postoperatively.

 
To compare analgesic efficacy in terms of Pain Scores in the first 24 hours postoperatively.

 
 
Secondary Outcome  
Outcome  TimePoints 
•To compare safety profile measured by sedation score and hemodynamic parameters up to 48 hours post operatively
•To compare pain scores in the next 24 hours, up to 48 hours postoperatively

 
Postoperatively
Postoperatively 
 
Target Sample Size   Total Sample Size="72"
Sample Size from India="72" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   04/03/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This is a Randomized Double blind-study to compare analgesic efficacy and safety of two different doses of Dexmedetomidine for continuous Epidural post-operative analgesia in lower limb surgeries. Primary outcome is to compare analgesic efficacy in terms of Pain Scores in the first 24 hours postoperatively. The secondary outcome is to compare the safety profile measured by sedation score and hemodynamic parameters up to 48 hours postoperatively and to compare pain scores in the next 24 hours, up to 48 hours postoperatively

 

 



 

 
Close